Parkinson's disease (PD) is a common neurodegenerative disease developed due to the
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …

Metformin is a first-line drug for treating type 2 diabetes mellitus (T2DM) and one of the most
commonly prescribed drugs in the world. Besides its hypoglycemic effects, metformin also …

Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by the
progressive loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and …

Background Alzheimer disease (AD) and other tauopathies develop cerebral intracellular
inclusions of hyperphosphorylated tau. Epidemiological and experimental evidence …

Background and aims Aging becomes a growing global concern with an increased risk of
neurodegenerative diseases (NDs) that mainly consist of cognitive decline and Parkinson …

Several useful animal models for parkinsonism have been developed so far. Haloperidol‐
induced catalepsy is often used as a rodent model for the study of motor impairments …

Introduction: Cerium oxide nanoparticles (CONPs) have been investigated for their
therapeutic potential in Parkinson's disease (PD) due to their potent and regenerative …

Diabetes mellitus and depression are the common comorbid disorders affecting humans
worldwide. There is an unmet need to develop therapeutic strategies to treat both diabetes …

Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies
show it has wide ranging effects to treat other diseases. Animal and retrospective human …

Parkinson's disease (PD) is a neurodegenerative disorder linked with aging and primarily
involves dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc). The …